Search results
Dividend Investors: Don't Be Too Quick To Buy AbbVie Inc. (NYSE:ABBV) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance Canada· 1 hour agoThe company's next dividend payment will be US$1.55 per share, and in the last 12 months, the...
The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
Zacks via Yahoo Finance Canada· 5 hours ago(You can read the full research report on United-Guardian here >>>) Why Haven’t You Looked at Zacks'...
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
Zacks via Yahoo Finance Canada· 21 hours agoWith the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to...
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance Canada· 1 day agoFor most investors, how much a stock's price changes over time is important. This factor can impact...
Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?
Zacks via Yahoo Finance Canada· 1 day agoAnd, most ETFs are very transparent products that disclose...CVX) accounts for about 9.83% of total...
Eli Lilly (LLY) to Buy Morphic for $3.2B, Boost IBD Presence
Zacks via Yahoo Finance Canada· 2 days agoEli Lilly's (LLY) acquisition of Morphic (MORF) is set to expand its immunology pipeline by adding...
Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value
GuruFocus.com via Yahoo Finance Canada· 2 days agoAs of 2024-07-09, AbbVie Inc's intrinsic value as calculated by the Discounted Earnings model is...
Stocks Are on a Record-Setting Tear. Where They Go From Here and 4 Other Things to Know Today.
Barrons.com· 2 days agoSouthwest rebuffs activist Elliott’s threat to appeal directly to shareholders, Eli Lilly is buying...
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Zacks via Yahoo Finance Canada· 3 days agoThe traditional ways to plan for your retirement may mean income can no longer cover expenses...
Eli Lilly to buy bowel disease drug developer Morphic for US$3.2-billion
The Globe and Mail· 3 days agoShares of drug developer Morphic surged 76 per cent to $56.15 premarket on Lilly’s offer of $57 per...